Agrios Global Holdings Ltd. Announces Dr. Curt Livesay, Director of Agronomy is Guest Columnist and Webinar Co-host at Cannabis Business Times

VANCOUVER, Oct. 7, 2019 /CNW/ - Agrios Global Holdings Ltd. (CSE: AGRO) (OTCQB: AGGHF) (FSE: ØSA - WKN-A2N62K) ("Agrios" or the "Company") announces Dr. Curt Livesay, Director of Agronomy at Agrios is featured as a guest columnist in the October 2019 issue of Cannabis Business Times.  Additionally, Dr. Livesay will co-host a webinar on Tuesday, October 8, 2019, with Andrea Sparr-Jaswa, Science Editor, of the Cannabis Business Times, and Cannabis Dispensary.

Dr. Livesay serves as the Director of Agronomy at Agrios, a data analytics-driven agriculture technology company advancing the latest innovations in indoor growing science. Agrios provides qualified licencees with advanced automated aeroponic facilities that allow for precise control of growing environments, providing cultivators with lower production costs, higher yields, and consistent premium crops.

Dr. Livesay notes in his column despite the fact that Cannabis sativa L. is a single species, there is some genetic evidence that supports the notion that there are at least two distinct subspecies of the plant, which initially appears to align with the sativa/indica distinction commonly ascribed to cannabis.

During the webinar, Dr. Livesay and Andrea Sparr-Jaswa will discuss sativa and indica chemovars or "strains" and how recent research studies have demonstrated that, contrary to popular belief, visible plant characteristics (e.g., leaf width, plant height) are not unique to either subspecies, and the true subspecies' differentiating characteristics often do not sync with labels attached to them and subsequently presented to the mass market. In addition, because of genetic variability, environmental conditions, and naming practices, cannabis products on the market can create inconsistencies and unpredicatability for patients and consumers, as evidenced by research provided and referenced in Dr. Livesay's column.

Consumers and cannabis growers alike must understand the implications of characterizing the cultivars that are being sold into the legal market.  Retailers must know how to position these products for a consumer and patient base that relies on cannabis businesses for education, guidance, accuracy and, consistency.

Dr. Livesay welcomes all interested parties to join the webinar being being held on October 8^th, 2019, 1:00 PM EST (10:00 AM PST) click https://register.gotowebinar.com/register/4461441454626556429 to register and receive your log in for the session.

About Agrios Global Holdings Ltd.

Agrios Global Holdings is a data analytics-driven agriculture technology and services company advancing the latest innovations in indoor growing science. The Company owns, leases and manages properties and equipment for eco-sustainable agronomy and provides advisory services to support all aspects of aeroponic cultivation in the cannabis sector. Agrios is actively pursuing new opportunities to expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions. Based in Vancouver, BC. Agrios is managed by a highly accomplished team of experienced industry and capital markets experts who are committed to the growth of the company.

This news release was prepared by management of Agrios, which takes full responsibility for its contents. The Canadian Securities Exchange ("CSE") has not reviewed and does not accept responsibility for the adequacy of this news release.  Neither the CSE nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Agrios' periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to corporate strategy and Agrios' ability to execute such strategy, future developments regarding Agrios' expansion into various markets including numerous states within the United States of America, and into Asia, expected costs of hemp fiber, intended development and sales of hemp products, market demand for hemp products, and the business and operations of Agrios as it relates to the Yunnan Province

Although Agrios has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Agrios disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Agrios does not assume any liability for disclosure relating to any other company mentioned herein.

SOURCE Agrios Global Holdings Ltd.

Ute Koessler, T: 604-336-2444, [email protected]